vs
Side-by-side financial comparison of Elanco Animal Health Inc (ELAN) and CHART INDUSTRIES INC (GTLS). Click either name above to swap in a different company.
Elanco Animal Health Inc is the larger business by last-quarter revenue ($1.1B vs $1.1B, roughly 1.1× CHART INDUSTRIES INC). CHART INDUSTRIES INC runs the higher net margin — 5.0% vs -24.1%, a 29.1% gap on every dollar of revenue. On growth, Elanco Animal Health Inc posted the faster year-over-year revenue change (12.2% vs -2.5%). CHART INDUSTRIES INC produced more free cash flow last quarter ($66.2M vs $46.0M). Over the past eight quarters, CHART INDUSTRIES INC's revenue compounded faster (6.6% CAGR vs -2.6%).
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
Oricon Inc. , established in 1999, is the holding company at the head of a Japanese corporate group that supplies statistics and information on music and the music industry in Japan and Western music. It started as Original Confidence Inc. , which was founded by Sōkō Koike in November 1967 and became known for its music charts. Oricon Inc. was originally set up as a subsidiary of Original Confidence and took over the latter's Oricon record charts in April 2002.
ELAN vs GTLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.1B |
| Net Profit | $-276.0M | $53.6M |
| Gross Margin | 51.5% | 33.3% |
| Operating Margin | -22.6% | 11.6% |
| Net Margin | -24.1% | 5.0% |
| Revenue YoY | 12.2% | -2.5% |
| Net Profit YoY | -3350.0% | -32.7% |
| EPS (diluted) | $-0.55 | $1.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $1.2B | $1.0B | ||
| Q1 24 | $1.2B | $950.7M |
| Q4 25 | $-276.0M | $53.6M | ||
| Q3 25 | $-34.0M | $-138.5M | ||
| Q2 25 | $11.0M | $76.1M | ||
| Q1 25 | $67.0M | $49.5M | ||
| Q4 24 | $-8.0M | $79.6M | ||
| Q3 24 | $364.0M | $69.0M | ||
| Q2 24 | $-50.0M | $58.6M | ||
| Q1 24 | $32.0M | $11.3M |
| Q4 25 | 51.5% | 33.3% | ||
| Q3 25 | 53.4% | 34.1% | ||
| Q2 25 | 57.5% | 33.6% | ||
| Q1 25 | 57.3% | 33.9% | ||
| Q4 24 | 50.9% | 33.6% | ||
| Q3 24 | 52.2% | 34.1% | ||
| Q2 24 | 58.2% | 33.8% | ||
| Q1 24 | 57.3% | 31.8% |
| Q4 25 | -22.6% | 11.6% | ||
| Q3 25 | -4.4% | -8.0% | ||
| Q2 25 | 2.0% | 15.7% | ||
| Q1 25 | 5.0% | 15.2% | ||
| Q4 24 | -5.0% | 17.0% | ||
| Q3 24 | 54.3% | 16.8% | ||
| Q2 24 | -2.7% | 16.1% | ||
| Q1 24 | 1.0% | 11.9% |
| Q4 25 | -24.1% | 5.0% | ||
| Q3 25 | -3.0% | -12.6% | ||
| Q2 25 | 0.9% | 7.0% | ||
| Q1 25 | 5.6% | 4.9% | ||
| Q4 24 | -0.8% | 7.2% | ||
| Q3 24 | 35.3% | 6.5% | ||
| Q2 24 | -4.2% | 5.6% | ||
| Q1 24 | 2.7% | 1.2% |
| Q4 25 | $-0.55 | $1.06 | ||
| Q3 25 | $-0.07 | $-3.23 | ||
| Q2 25 | $0.02 | $1.53 | ||
| Q1 25 | $0.13 | $0.94 | ||
| Q4 24 | $-0.01 | $1.57 | ||
| Q3 24 | $0.73 | $1.33 | ||
| Q2 24 | $-0.10 | $1.10 | ||
| Q1 24 | $0.06 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $545.0M | $366.0M |
| Total DebtLower is stronger | $3.9B | $3.7B |
| Stockholders' EquityBook value | $6.5B | $3.2B |
| Total Assets | $13.4B | $9.8B |
| Debt / EquityLower = less leverage | 0.60× | 1.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $545.0M | $366.0M | ||
| Q3 25 | $505.0M | $399.2M | ||
| Q2 25 | $539.0M | $342.3M | ||
| Q1 25 | $487.0M | $296.2M | ||
| Q4 24 | $468.0M | $308.6M | ||
| Q3 24 | $490.0M | $310.2M | ||
| Q2 24 | $416.0M | $247.4M | ||
| Q1 24 | $345.0M | $191.9M |
| Q4 25 | $3.9B | $3.7B | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | $3.8B | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.8B | — |
| Q4 25 | $6.5B | $3.2B | ||
| Q3 25 | $6.7B | $3.2B | ||
| Q2 25 | $6.8B | $3.4B | ||
| Q1 25 | $6.4B | $3.0B | ||
| Q4 24 | $6.1B | $2.8B | ||
| Q3 24 | $6.5B | $3.0B | ||
| Q2 24 | $5.9B | $2.7B | ||
| Q1 24 | $6.1B | $2.7B |
| Q4 25 | $13.4B | $9.8B | ||
| Q3 25 | $13.6B | $9.8B | ||
| Q2 25 | $13.7B | $9.7B | ||
| Q1 25 | $12.9B | $9.3B | ||
| Q4 24 | $12.6B | $9.1B | ||
| Q3 24 | $13.3B | $9.5B | ||
| Q2 24 | $13.8B | $9.3B | ||
| Q1 24 | $14.0B | $9.2B |
| Q4 25 | 0.60× | 1.13× | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.70× | 1.33× | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.0M | $88.8M |
| Free Cash FlowOCF − Capex | $46.0M | $66.2M |
| FCF MarginFCF / Revenue | 4.0% | 6.1% |
| Capex IntensityCapex / Revenue | 5.4% | 2.1% |
| Cash ConversionOCF / Net Profit | — | 1.66× |
| TTM Free Cash FlowTrailing 4 quarters | $284.0M | $202.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.0M | $88.8M | ||
| Q3 25 | $219.0M | $118.0M | ||
| Q2 25 | $237.0M | $145.9M | ||
| Q1 25 | $-4.0M | $-60.0M | ||
| Q4 24 | $177.0M | $281.4M | ||
| Q3 24 | $162.0M | $200.6M | ||
| Q2 24 | $200.0M | $116.1M | ||
| Q1 24 | $2.0M | $-95.1M |
| Q4 25 | $46.0M | $66.2M | ||
| Q3 25 | $127.0M | $94.7M | ||
| Q2 25 | $180.0M | $122.0M | ||
| Q1 25 | $-69.0M | $-80.1M | ||
| Q4 24 | $130.0M | $260.9M | ||
| Q3 24 | $120.0M | $174.5M | ||
| Q2 24 | $166.0M | $88.0M | ||
| Q1 24 | $-22.0M | $-141.2M |
| Q4 25 | 4.0% | 6.1% | ||
| Q3 25 | 11.2% | 8.6% | ||
| Q2 25 | 14.5% | 11.3% | ||
| Q1 25 | -5.8% | -8.0% | ||
| Q4 24 | 12.7% | 23.6% | ||
| Q3 24 | 11.7% | 16.4% | ||
| Q2 24 | 14.0% | 8.5% | ||
| Q1 24 | -1.8% | -14.9% |
| Q4 25 | 5.4% | 2.1% | ||
| Q3 25 | 8.1% | 2.1% | ||
| Q2 25 | 4.6% | 2.2% | ||
| Q1 25 | 5.4% | 2.0% | ||
| Q4 24 | 4.6% | 1.9% | ||
| Q3 24 | 4.1% | 2.5% | ||
| Q2 24 | 2.9% | 2.7% | ||
| Q1 24 | 2.0% | 4.8% |
| Q4 25 | — | 1.66× | ||
| Q3 25 | — | — | ||
| Q2 25 | 21.55× | 1.92× | ||
| Q1 25 | -0.06× | -1.21× | ||
| Q4 24 | — | 3.54× | ||
| Q3 24 | 0.45× | 2.91× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | 0.06× | -8.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
GTLS
| Repair Service And Leasing Segment | $330.4M | 31% |
| Heat Transfer Systems Segment | $325.8M | 30% |
| Specialty Products Segment | $259.5M | 24% |
| Transferred Over Time | $94.4M | 9% |
| Transferred At Point In Time | $69.5M | 6% |
